NOUGUES MAXIMO F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-06$5.84/sh−4,540$26,532→ 199,689 total - Sale
Common Stock
2026-01-07$5.88/sh−6,405$37,655→ 193,284 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-14-2020